Author:
Sheikh Muhammad Muhye-ud-din,Trapnell Bruce C.
Reference113 articles.
1. Akasaka K, Tanaka T, Maruyama T, Kitamura N, Hashimoto A, Ito Y, Watanabe H, Wakayama T, Arai T, Hayashi M, Moriyama H, Uchida K, Ohkouchi S, Tazawa R, Takada T, Yamaguchi E, Ichiwata T, Hirose M, Arai T, Inoue Y, Kobayashi H, Nakata K (2015) A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosis. Am J Physiol Lung Cell Mol Physiol 308:L105–L117
2. Amital A, Dux S, Shitrit D, Shpilberg O, Kramer MR (2010) Therapeutic effectiveness of rituximab in a patient with unresponsive autoimmune pulmonary alveolar proteinosis. Thorax 65:1025–1026
3. Arai T, Inoue Y, Sugimoto C, Inoue Y, Nakao K, Takeuchi N, Matsumuro A, Hirose M, Nakata K, Hayashi S (2014) CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis. Respirology 19:246–252
4. Asamoto H, Kitaichi M, Nishimura K, Itoh H, Izumi T (1995) Primary pulmonary alveolar proteinosis—clinical observation of 68 patients in Japan. Nihon Kyobu Shikkan Gakkai Zasshi 33:835–845
5. Bachofen H, Schurch S (2001) Alveolar surface forces and lung architecture. Comp Biochem Physiol A Mol Integr Physiol 129:183–193